BMY vs MRK
Bristol Myers Squibb (BMY) and Merck (MRK) compared side by side. Merck (MRK) is larger, with a market cap of $358.4B versus $125.6B for Bristol Myers Squibb, about 2.9 times the size. On trailing earnings, BMY is cheaper at 13.5x versus 117.2x for MRK.
Head to head
| Metric | BMY | MRK |
|---|---|---|
| Market cap | $125.6B | $358.4B |
| P/E (TTM) | 13.5x | 117.2x |
| Forward P/E | 9.3x | 15.7x |
| Revenue (TTM) | $49.2B | $66.6B |
| Revenue growth | 5.7% | 5.1% |
| Gross margin | 71.7% | 75.9% |
| Operating margin | 34.4% | -0.2% |
| Free cash flow | $11.4B | $16.1B |
| Dividend yield | 4.10% | 2.34% |
| 1-year return | +46.5% | +71.5% |
| 5-year return (annual) | +5.6% | +15.8% |
| Max drawdown | -71% | -69% |
| FI Handbook grade | B | C |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
BMY vs MRK FAQ
Which is bigger, BMY or MRK?
Merck (MRK) is larger, with a market cap of $358.4B versus $125.6B for Bristol Myers Squibb, about 2.9 times the size.
Is BMY or MRK cheaper?
On trailing earnings, BMY is cheaper at 13.5x versus 117.2x for MRK. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, BMY or MRK?
MRK returned +71.5% over the past year including dividends, versus +46.5% for BMY, through October 23, 2026.
Which pays a higher dividend, BMY or MRK?
BMY yields 4.10% versus 2.34% for MRK.
Full pages: Bristol Myers Squibb · Merck